This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Clostridium tetani

Authoring team

Clostridium tetani is a gram positive bacilli that causes tetanus. This organism exists as a gut commensal as well as in the soil. The organism remains localized at the portal of entry, but produces an exotoxin (tetanospasmin) which acts on the CNS. Also, it produces an oxygen-labile haemolysin of unknown pathogenicity.

C. tetani bears spherical spores in its terminal regions which are resistant to drying and antiseptics. The spores are also partly resistant to heat. Morphologically, the appearance of bacilli with spores has been likened to a 'drumstick'.

C. tetani is a strict anaerobe. It can grow on ordinary media at 37 degrees centigrade to produce a spreading, thin growth that is often poorly visible.

Tetanospasmin reaches the central nervous system by intraaxonal transport, moving at a rate of 75 to 250 nm per day (1).

  • this toxin produces presynaptic blockade of the synapses on inhibitory Renshaw cells and Ia fibres of alpha motor neurons that handle the transmission of gamma - aminobutyric and glycine, but not of the Renshaw cells that handle acetylcholine transmission
  • tetanospasmin binding appears to be irreversible
  • recovery of function depends on the sprouting of new axonal terminals

Reference:

  • Sanford JP (1995). Tetanus - forgotten but not gone. NEJM, 332, 812-3.

Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.